跳至主要内容
临床试验/EUCTR2009-015620-29-BE
EUCTR2009-015620-29-BE进行中(未招募)不适用

The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance.

未提供0 个研究点目标入组 30 人开始时间: 2010年2月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The participants to this study are aged between 4 and 12 years and have a diagnosis of congenital hemiplegia affecting upper-limb activities but not significative fixed contractures.
  • They have a Manual Ability Classification system( MACS) level between 1 and 4 and a normal education or an IQ > 70.
  • They must have an adapted physiotherapy program before and minimum 9 months after the treatment.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • The children who had injection within 6 months previous the inclusion in the lower limb and 9 months in the upper limb will be excluded. Children who participated at a constraint-induced therapy (CIMT) program the year before the study will be automatically excluded.

研究者

发起方
未提供

相似试验